Mankind Pharma's Stock Performance Shines, Outperforms Sector and Sensex

Oct 31 2024 01:50 PM IST
share
Share Via
Mankind Pharma, a leading pharmaceutical company in India, has been gaining attention with its recent stock performance. On October 31, 2024, the stock gained 3.07%, outperforming the sector by 1.68%. In the last 3 days, the stock has risen by 11.06%, reaching an intraday high of Rs 2730. It is also trading higher than its moving averages and has outperformed the Sensex in both short and long term. With its strong performance and market dominance, Mankind Pharma remains a top player in the industry and a promising investment option.
Mankind Pharma's Stock Performance Shines, Outperforms Sector and Sensex
Mankind Pharma, a leading pharmaceutical company in India, has been making headlines with its recent stock performance. On October 31, 2024, the company's stock gained 3.07%, outperforming the sector by 1.68%. This positive trend has caught the attention of investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock. In the last 3 days, Mankind Pharma's stock has been on a consecutive rise, with a total gain of 11.06%. This is a significant increase and showcases the company's strong performance in the market. On the same day, the stock also touched an intraday high of Rs 2730, a 4.35% increase from the previous day. Mankind Pharma's stock is also trading higher than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. This indicates a positive trend and further strengthens the company's position in the market. In comparison to the Sensex performance, Mankind Pharma has outperformed with a 1 day performance of 3.05% while the Sensex saw a -0.58% decrease. Similarly, in the last month, Mankind Pharma's stock has shown a 4.16% increase while the Sensex saw a -5.69% decrease. With such strong performance and positive indicators, Mankind Pharma continues to be a top player in the pharmaceutical industry. Its consistent growth and market dominance make it a promising investment option for investors.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2016
Feb 20 2026 03:46 PM IST
share
Share Via
Mankind Pharma Ltd is Rated Sell
Feb 18 2026 10:10 AM IST
share
Share Via
Mankind Pharma Ltd is Rated Sell by MarketsMOJO
Feb 07 2026 10:10 AM IST
share
Share Via
Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2029.35
Feb 06 2026 11:26 AM IST
share
Share Via
Are Mankind Pharma Ltd latest results good or bad?
Feb 04 2026 07:24 PM IST
share
Share Via